The global market for General Anesthetic for Surgery was estimated to be worth US$ 3926 million in 2023 and is forecast to a readjusted size of US$ 4983.4 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

General Anesthetic for Surgery - Market

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.

The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for General Anesthetic for Surgery, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of General Anesthetic for Surgery by region & country, by Type, and by Application.

The General Anesthetic for Surgery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthetic for Surgery.

Market Segmentation

Scope of General Anesthetic for Surgery - Market Report

Report Metric	Details
Report Name	General Anesthetic for Surgery - Market
Forecasted market size in 2030	US$ 4983.4 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	Propofol Sevoflurane Remifentanil Etomidate Isoflurane Other
Segment by Application	Intravenous Anesthetics Inhalational Anesthetics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of General Anesthetic for Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of General Anesthetic for Surgery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the General Anesthetic for Surgery - Market size in 2030?

Ans: The General Anesthetic for Surgery - Market size in 2030 will be US$ 4983.4 million.

Who are the main players in the General Anesthetic for Surgery - Market report?

Ans: The main players in the General Anesthetic for Surgery - Market are Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals, Yichang Humanwell, Nhwa, Hengrui, Xi'an Libang

What are the Application segmentation covered in the General Anesthetic for Surgery - Market report?

Ans: The Applications covered in the General Anesthetic for Surgery - Market report are Intravenous Anesthetics, Inhalational Anesthetics

What are the Type segmentation covered in the General Anesthetic for Surgery - Market report?

Ans: The Types covered in the General Anesthetic for Surgery - Market report are Propofol, Sevoflurane, Remifentanil, Etomidate, Isoflurane, Other

1 Market Overview

1.1 General Anesthetic for Surgery Product Introduction

1.2 Global General Anesthetic for Surgery Market Size Forecast

1.2.1 Global General Anesthetic for Surgery Sales Value (2019-2030)

1.2.2 Global General Anesthetic for Surgery Sales Volume (2019-2030)

1.2.3 Global General Anesthetic for Surgery Sales Price (2019-2030)

1.3 General Anesthetic for Surgery Market Trends & Drivers

1.3.1 General Anesthetic for Surgery Industry Trends

1.3.2 General Anesthetic for Surgery Market Drivers & Opportunity

1.3.3 General Anesthetic for Surgery Market Challenges

1.3.4 General Anesthetic for Surgery Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global General Anesthetic for Surgery Players Revenue Ranking (2023)

2.2 Global General Anesthetic for Surgery Revenue by Company (2019-2024)

2.3 Global General Anesthetic for Surgery Players Sales Volume Ranking (2023)

2.4 Global General Anesthetic for Surgery Sales Volume by Company Players (2019-2024)

2.5 Global General Anesthetic for Surgery Average Price by Company (2019-2024)

2.6 Key Manufacturers General Anesthetic for Surgery Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers General Anesthetic for Surgery Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of General Anesthetic for Surgery

2.9 General Anesthetic for Surgery Market Competitive Analysis

2.9.1 General Anesthetic for Surgery Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by General Anesthetic for Surgery Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthetic for Surgery as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Propofol

3.1.2 Sevoflurane

3.1.3 Remifentanil

3.1.4 Etomidate

3.1.5 Isoflurane

3.1.6 Other

3.2 Global General Anesthetic for Surgery Sales Value by Type

3.2.1 Global General Anesthetic for Surgery Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global General Anesthetic for Surgery Sales Value, by Type (2019-2030)

3.2.3 Global General Anesthetic for Surgery Sales Value, by Type (%) (2019-2030)

3.3 Global General Anesthetic for Surgery Sales Volume by Type

3.3.1 Global General Anesthetic for Surgery Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global General Anesthetic for Surgery Sales Volume, by Type (2019-2030)

3.3.3 Global General Anesthetic for Surgery Sales Volume, by Type (%) (2019-2030)

3.4 Global General Anesthetic for Surgery Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Intravenous Anesthetics

4.1.2 Inhalational Anesthetics

4.2 Global General Anesthetic for Surgery Sales Value by Application

4.2.1 Global General Anesthetic for Surgery Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global General Anesthetic for Surgery Sales Value, by Application (2019-2030)

4.2.3 Global General Anesthetic for Surgery Sales Value, by Application (%) (2019-2030)

4.3 Global General Anesthetic for Surgery Sales Volume by Application

4.3.1 Global General Anesthetic for Surgery Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global General Anesthetic for Surgery Sales Volume, by Application (2019-2030)

4.3.3 Global General Anesthetic for Surgery Sales Volume, by Application (%) (2019-2030)

4.4 Global General Anesthetic for Surgery Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global General Anesthetic for Surgery Sales Value by Region

5.1.1 Global General Anesthetic for Surgery Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global General Anesthetic for Surgery Sales Value by Region (2019-2024)

5.1.3 Global General Anesthetic for Surgery Sales Value by Region (2025-2030)

5.1.4 Global General Anesthetic for Surgery Sales Value by Region (%), (2019-2030)

5.2 Global General Anesthetic for Surgery Sales Volume by Region

5.2.1 Global General Anesthetic for Surgery Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global General Anesthetic for Surgery Sales Volume by Region (2019-2024)

5.2.3 Global General Anesthetic for Surgery Sales Volume by Region (2025-2030)

5.2.4 Global General Anesthetic for Surgery Sales Volume by Region (%), (2019-2030)

5.3 Global General Anesthetic for Surgery Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America General Anesthetic for Surgery Sales Value, 2019-2030

5.4.2 North America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe General Anesthetic for Surgery Sales Value, 2019-2030

5.5.2 Europe General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific General Anesthetic for Surgery Sales Value, 2019-2030

5.6.2 Asia Pacific General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America General Anesthetic for Surgery Sales Value, 2019-2030

5.7.2 South America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa General Anesthetic for Surgery Sales Value, 2019-2030

5.8.2 Middle East & Africa General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions General Anesthetic for Surgery Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions General Anesthetic for Surgery Sales Value

6.2.1 Key Countries/Regions General Anesthetic for Surgery Sales Value, 2019-2030

6.2.2 Key Countries/Regions General Anesthetic for Surgery Sales Volume, 2019-2030

6.3 United States

6.3.1 United States General Anesthetic for Surgery Sales Value, 2019-2030

6.3.2 United States General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.3.3 United States General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe General Anesthetic for Surgery Sales Value, 2019-2030

6.4.2 Europe General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China General Anesthetic for Surgery Sales Value, 2019-2030

6.5.2 China General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.5.3 China General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan General Anesthetic for Surgery Sales Value, 2019-2030

6.6.2 Japan General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea General Anesthetic for Surgery Sales Value, 2019-2030

6.7.2 South Korea General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia General Anesthetic for Surgery Sales Value, 2019-2030

6.8.2 Southeast Asia General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India General Anesthetic for Surgery Sales Value, 2019-2030

6.9.2 India General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

6.9.3 India General Anesthetic for Surgery Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Aspen Pharma

7.1.1 Aspen Pharma Company Information

7.1.2 Aspen Pharma Introduction and Business Overview

7.1.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Aspen Pharma General Anesthetic for Surgery Product Offerings

7.1.5 Aspen Pharma Recent Development

7.2 Fresenius-Kabi

7.2.1 Fresenius-Kabi Company Information

7.2.2 Fresenius-Kabi Introduction and Business Overview

7.2.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Fresenius-Kabi General Anesthetic for Surgery Product Offerings

7.2.5 Fresenius-Kabi Recent Development

7.3 AbbVie

7.3.1 AbbVie Company Information

7.3.2 AbbVie Introduction and Business Overview

7.3.3 AbbVie General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.3.4 AbbVie General Anesthetic for Surgery Product Offerings

7.3.5 AbbVie Recent Development

7.4 Baxter Healthcare

7.4.1 Baxter Healthcare Company Information

7.4.2 Baxter Healthcare Introduction and Business Overview

7.4.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Baxter Healthcare General Anesthetic for Surgery Product Offerings

7.4.5 Baxter Healthcare Recent Development

7.5 B.Braun

7.5.1 B.Braun Company Information

7.5.2 B.Braun Introduction and Business Overview

7.5.3 B.Braun General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.5.4 B.Braun General Anesthetic for Surgery Product Offerings

7.5.5 B.Braun Recent Development

7.6 Maruishi

7.6.1 Maruishi Company Information

7.6.2 Maruishi Introduction and Business Overview

7.6.3 Maruishi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Maruishi General Anesthetic for Surgery Product Offerings

7.6.5 Maruishi Recent Development

7.7 Piramal

7.7.1 Piramal Company Information

7.7.2 Piramal Introduction and Business Overview

7.7.3 Piramal General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Piramal General Anesthetic for Surgery Product Offerings

7.7.5 Piramal Recent Development

7.8 Hikma Pharmaceuticals

7.8.1 Hikma Pharmaceuticals Company Information

7.8.2 Hikma Pharmaceuticals Introduction and Business Overview

7.8.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Offerings

7.8.5 Hikma Pharmaceuticals Recent Development

7.9 Yichang Humanwell

7.9.1 Yichang Humanwell Company Information

7.9.2 Yichang Humanwell Introduction and Business Overview

7.9.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Yichang Humanwell General Anesthetic for Surgery Product Offerings

7.9.5 Yichang Humanwell Recent Development

7.10 Nhwa

7.10.1 Nhwa Company Information

7.10.2 Nhwa Introduction and Business Overview

7.10.3 Nhwa General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Nhwa General Anesthetic for Surgery Product Offerings

7.10.5 Nhwa Recent Development

7.11 Hengrui

7.11.1 Hengrui Company Information

7.11.2 Hengrui Introduction and Business Overview

7.11.3 Hengrui General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hengrui General Anesthetic for Surgery Product Offerings

7.11.5 Hengrui Recent Development

7.12 Xi'an Libang

7.12.1 Xi'an Libang Company Information

7.12.2 Xi'an Libang Introduction and Business Overview

7.12.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Xi'an Libang General Anesthetic for Surgery Product Offerings

7.12.5 Xi'an Libang Recent Development

8 Industry Chain Analysis

8.1 General Anesthetic for Surgery Industrial Chain

8.2 General Anesthetic for Surgery Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 General Anesthetic for Surgery Sales Model

8.5.2 Sales Channel

8.5.3 General Anesthetic for Surgery Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Hikma Pharmaceuticals

List of Tables

Table 1. General Anesthetic for Surgery Market Trends

Table 2. General Anesthetic for Surgery Market Drivers & Opportunity

Table 3. General Anesthetic for Surgery Market Challenges

Table 4. General Anesthetic for Surgery Market Restraints

Table 5. Global General Anesthetic for Surgery Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global General Anesthetic for Surgery Revenue Market Share by Company (2019-2024)

Table 7. Global General Anesthetic for Surgery Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global General Anesthetic for Surgery Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market General Anesthetic for Surgery Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers General Anesthetic for Surgery Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers General Anesthetic for Surgery Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of General Anesthetic for Surgery

Table 13. Global General Anesthetic for Surgery Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anesthetic for Surgery as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global General Anesthetic for Surgery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global General Anesthetic for Surgery Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global General Anesthetic for Surgery Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global General Anesthetic for Surgery Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global General Anesthetic for Surgery Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global General Anesthetic for Surgery Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global General Anesthetic for Surgery Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global General Anesthetic for Surgery Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global General Anesthetic for Surgery Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global General Anesthetic for Surgery Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global General Anesthetic for Surgery Price by Type (2019-2024) & (US$/Unit)

Table 27. Global General Anesthetic for Surgery Price by Type (2025-2030) & (US$/Unit)

Table 28. Global General Anesthetic for Surgery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global General Anesthetic for Surgery Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global General Anesthetic for Surgery Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global General Anesthetic for Surgery Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global General Anesthetic for Surgery Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global General Anesthetic for Surgery Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global General Anesthetic for Surgery Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global General Anesthetic for Surgery Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global General Anesthetic for Surgery Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global General Anesthetic for Surgery Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global General Anesthetic for Surgery Price by Application (2019-2024) & (US$/Unit)

Table 39. Global General Anesthetic for Surgery Price by Application (2025-2030) & (US$/Unit)

Table 40. Global General Anesthetic for Surgery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global General Anesthetic for Surgery Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global General Anesthetic for Surgery Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global General Anesthetic for Surgery Sales Value by Region (2019-2024) & (%)

Table 44. Global General Anesthetic for Surgery Sales Value by Region (2025-2030) & (%)

Table 45. Global General Anesthetic for Surgery Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global General Anesthetic for Surgery Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global General Anesthetic for Surgery Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global General Anesthetic for Surgery Sales Volume by Region (2019-2024) & (%)

Table 49. Global General Anesthetic for Surgery Sales Volume by Region (2025-2030) & (%)

Table 50. Global General Anesthetic for Surgery Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global General Anesthetic for Surgery Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions General Anesthetic for Surgery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions General Anesthetic for Surgery Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions General Anesthetic for Surgery Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions General Anesthetic for Surgery Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions General Anesthetic for Surgery Sales Volume, (2025-2030) & (K Units)

Table 57. Aspen Pharma Company Information

Table 58. Aspen Pharma Introduction and Business Overview

Table 59. Aspen Pharma General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Aspen Pharma General Anesthetic for Surgery Product Offerings

Table 61. Aspen Pharma Recent Development

Table 62. Fresenius-Kabi Company Information

Table 63. Fresenius-Kabi Introduction and Business Overview

Table 64. Fresenius-Kabi General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Fresenius-Kabi General Anesthetic for Surgery Product Offerings

Table 66. Fresenius-Kabi Recent Development

Table 67. AbbVie Company Information

Table 68. AbbVie Introduction and Business Overview

Table 69. AbbVie General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. AbbVie General Anesthetic for Surgery Product Offerings

Table 71. AbbVie Recent Development

Table 72. Baxter Healthcare Company Information

Table 73. Baxter Healthcare Introduction and Business Overview

Table 74. Baxter Healthcare General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Baxter Healthcare General Anesthetic for Surgery Product Offerings

Table 76. Baxter Healthcare Recent Development

Table 77. B.Braun Company Information

Table 78. B.Braun Introduction and Business Overview

Table 79. B.Braun General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. B.Braun General Anesthetic for Surgery Product Offerings

Table 81. B.Braun Recent Development

Table 82. Maruishi Company Information

Table 83. Maruishi Introduction and Business Overview

Table 84. Maruishi General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Maruishi General Anesthetic for Surgery Product Offerings

Table 86. Maruishi Recent Development

Table 87. Piramal Company Information

Table 88. Piramal Introduction and Business Overview

Table 89. Piramal General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Piramal General Anesthetic for Surgery Product Offerings

Table 91. Piramal Recent Development

Table 92. Hikma Pharmaceuticals Company Information

Table 93. Hikma Pharmaceuticals Introduction and Business Overview

Table 94. Hikma Pharmaceuticals General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Hikma Pharmaceuticals General Anesthetic for Surgery Product Offerings

Table 96. Hikma Pharmaceuticals Recent Development

Table 97. Yichang Humanwell Company Information

Table 98. Yichang Humanwell Introduction and Business Overview

Table 99. Yichang Humanwell General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Yichang Humanwell General Anesthetic for Surgery Product Offerings

Table 101. Yichang Humanwell Recent Development

Table 102. Nhwa Company Information

Table 103. Nhwa Introduction and Business Overview

Table 104. Nhwa General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Nhwa General Anesthetic for Surgery Product Offerings

Table 106. Nhwa Recent Development

Table 107. Hengrui Company Information

Table 108. Hengrui Introduction and Business Overview

Table 109. Hengrui General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Hengrui General Anesthetic for Surgery Product Offerings

Table 111. Hengrui Recent Development

Table 112. Xi'an Libang Company Information

Table 113. Xi'an Libang Introduction and Business Overview

Table 114. Xi'an Libang General Anesthetic for Surgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Xi'an Libang General Anesthetic for Surgery Product Offerings

Table 116. Xi'an Libang Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. General Anesthetic for Surgery Downstream Customers

Table 120. General Anesthetic for Surgery Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. General Anesthetic for Surgery Product Picture

Figure 2. Global General Anesthetic for Surgery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 4. Global General Anesthetic for Surgery Sales Volume (2019-2030) & (K Units)

Figure 5. Global General Anesthetic for Surgery Sales Price (2019-2030) & (US$/Unit)

Figure 6. General Anesthetic for Surgery Report Years Considered

Figure 7. Global General Anesthetic for Surgery Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global General Anesthetic for Surgery Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by General Anesthetic for Surgery Revenue in 2023

Figure 10. General Anesthetic for Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Propofol Picture

Figure 12. Sevoflurane Picture

Figure 13. Remifentanil Picture

Figure 14. Etomidate Picture

Figure 15. Isoflurane Picture

Figure 16. Other Picture

Figure 17. Global General Anesthetic for Surgery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global General Anesthetic for Surgery Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global General Anesthetic for Surgery Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global General Anesthetic for Surgery Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global General Anesthetic for Surgery Price by Type (2019-2030) & (US$/Unit)

Figure 22. Product Picture of Intravenous Anesthetics

Figure 23. Product Picture of Inhalational Anesthetics

Figure 24. Global General Anesthetic for Surgery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global General Anesthetic for Surgery Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global General Anesthetic for Surgery Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global General Anesthetic for Surgery Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global General Anesthetic for Surgery Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 30. North America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

Figure 35. South America General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 36. South America General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa General Anesthetic for Surgery Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa General Anesthetic for Surgery Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions General Anesthetic for Surgery Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions General Anesthetic for Surgery Sales Volume (%), (2019-2030)

Figure 41. United States General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 43. United States General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 47. China General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 48. China General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 49. China General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 59. India General Anesthetic for Surgery Sales Value, (2019-2030) & (US$ Million)

Figure 60. India General Anesthetic for Surgery Sales Value by Type (%), 2023 VS 2030

Figure 61. India General Anesthetic for Surgery Sales Value by Application (%), 2023 VS 2030

Figure 62. General Anesthetic for Surgery Industrial Chain

Figure 63. General Anesthetic for Surgery Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions